Glyscend's Grant - IV Round

Glyscend raised a round of funding on September 01, 2017. Investors include Small Business Innovation Research Awards.

Glyscend is developing an approach to treating type 2 diabetes by recreating the effects of bariatric surgery, like gastric bypass, for diabetes and obesity without the need for invasive procedures.…

Articles about Glyscend's Grant - IV Round: